John A. Corbett

Selective inhibition of the inducible nitric oxide synthase by aminoguanidine

Thomas P. Misko, William M. Moore, Thomas P. Kasten et al. · European Journal of Pharmacology · 1993 · 724 citations

Selective Inhibition, Molecular Pharmacology, Biochemistry +7

Aminoguanidine, a Novel Inhibitor of Nitric Oxide Formation, Prevents Diabetic Vascular Dysfunction

John A. Corbett, Ronald G. Tilton, Kathy Chang et al. · Diabetes · 1992 · 609 citations · Full text

Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans.

John A. Corbett, Michael A. Sweetland, Jaw‐Lin Wang et al. · Proceedings of the National Academy of Sciences · 1993 · 408 citations · Full text

Nitric Oxide, Immunology, Insulin Signaling +19

Expression of Neuregulins and their Putative Receptors, ErbB2 and ErbB3, Is Induced during Wallerian Degeneration

Steven L. Carroll, Michele L. Miller, Paul W. Frohnert et al. · Journal of Neuroscience · 1997 · 328 citations · Full text

Schwann Cell Dedifferentiation, Peripheral Nerve Injury, Cell Death +16

Prevention of Diabetic Vascular Dysfunction by Guanidines: Inhibition of Nitric Oxide Synthase Versus Advanced Glycation End-Product Formation

Ronald G. Tilton, Katherine Chang, Khalid S. Hasan et al. · Diabetes · 1993 · 288 citations